Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice

Clinical and Experimental Immunology

Volumn 126, Issue 2, 2001, Pages 220-229

  Gorczynski, R M ^a,c   Chen, Z ^a   Hu, J ^b   Kai, Y ^a   Lei, J ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

CD200; Co stimulation; Immunoregulation; Tumour immunity

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD200 ANTIGEN; CD200 RECEPTOR; CD200FC; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOADSORBENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; LEUKEMIA CELL; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STIMULUS RESPONSE; TRANSPLANTATION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, SURFACE; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; IMMUNE TOLERANCE; IMMUNIZATION; LEUKEMIA, EXPERIMENTAL; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; TRANSFECTION;

EID: 0034773243     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01689.x     Document Type: Article

References (37)

1. Specific manipulation of immunity to skin grafts bearing multiple minor histocompatibility differences
2. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage
3. Increased expression of the novel molecule Ox-2 is involved in prolongation of murine renal allograft survival
4. Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX-2 antigens
5. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival
6. Evidence that an OX-2 positive cell can inhibit the stimulation of type-1 cytokine production by bone-marrow-derived B7-1 (and B7-2) positive dendritic cells
7. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
8. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
9. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
10. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model
11. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8 (1) cytotoxic T lymphocytes in vitro
12. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice
13. Receptor engagement on cells expressing a ligand for the tolerance- inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo
14. Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
15. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope
16. Tumor antigen presentation: Changing the rules
17. Function and dysfunction of CD4 (1) T cells in the immune response to melanoma
18. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules
19. Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7
20. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro
21. Tumor immunotherapy: Cytokines and antigen presentation
22. Tumor's other immune targets: Dendritic cells
23. Restoration of alloreactivity of melanoma by transduction with B7.1
24. Gene transfer of the co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent
25. Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity
26. Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity
27. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells
28. Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2
29. Transplant tolerance modifying antibody to CD, 200 receptor (CD200r) but not CD, 200 alters cytokine production profile from stimulated macrophages
30. Graft-versus-leukemia effect and its clinical implications
31. Opposing roles of CD28 : B7 and CTLA-4 : B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells
32. Allogeneic hematopoietic transplantation as adoptive immunotherapy 2 induction of graft-versus-malignancy as primary therapy
33. Dependency upon intercellular adhesion molecule (ICAM) recognition and local IL-2 provision in generation of an in vivo CD81 T cell immune response to murine myeloid leukemia
34. Tumor immunogenicity determines the effect of B7 co-stimulation on T-cell mediated tumor immunity
35. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
36. Gamma delta TCR (+) hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo
37. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?